4.8 Article

Topological control of cytokine receptor signaling induces differential effects in hematopoiesis

期刊

SCIENCE
卷 364, 期 6442, 页码 750-+

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aav7532

关键词

-

资金

  1. NIH [R01-AI51321, T32HL066987, R01 DK103794, R33 HL120791, S10OD021832]
  2. Deutsche Forschungsgemeinschaft (DFG) [SFB 944]
  3. Howard Hughes Medical Institute (HHMI)
  4. National Cancer Institute [ACB-12002]
  5. National Institute of General Medical Sciences (NIGMS) [AGM-12006]
  6. DOE Office of Science [DE-AC02-06CH11357]
  7. NIH-Office of Research Infrastructure Programs, High-End Instrumentation Grant [1S10OD012289-01A1]
  8. HHMI
  9. DOE Office of Science User Facility [DE-AC02-05CH11231]
  10. DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]
  11. DOE Office of Biological and Environmental Research
  12. NIGMS [P41GM103393]
  13. Mathers Fund

向作者/读者索取更多资源

Although tunable signaling by G protein-coupled receptors can be exploited through medicinal chemistry, a comparable pharmacological approach has been lacking for the modulation of signaling through dimeric receptors, such as those for cytokines. We present a strategy to modulate cytokine receptor signaling output by use of a series of designed C2-symmetric cytokine mimetics, based on the designed ankyrin repeat protein (DARPin) scaffold, that can systematically control erythropoietin receptor (EpoR) dimerization orientation and distance between monomers. We sampled a range of EpoR geometries by varying intermonomer angle and distance, corroborated by several ligand-EpoRcomplex crystal structures. Across the range, we observed full, partial, and biased agonism as well as stage-selective effects on hematopoiesis. This surrogate ligand strategy opens access to pharmacological modulation of therapeutically important cytokine and growth factor receptor systems.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据